STOCK TITAN

Pharming Group N.V. (PHAR) EPS by Year

PHAR NASDAQ

Pharming Group N.V. earned $0.00 per diluted ordinary share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025.

FY2025 annual
EPS (Diluted) $0.00
YoY n/m
5Y CAGR -40.8%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Earnings and dividends per share are per ordinary share, and share counts are in ordinary shares. PHAR trades in the US as American depositary shares (ADSs), and one ADS represents 10 ordinary shares.

Annual figures, oldest first. Point at a bar to read its period.

PHAR EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-F
EPS (Diluted)$0.00n/m-$0.02n/m-$0.02-184.2%$0.02-17.4%$0.02-58.2%$0.06-8.3%$0.06

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Pharming Group N.V. financials

Frequently Asked Questions

Pharming Group N.V. earned $0.00 per diluted ordinary share in fiscal year 2025.

Pharming Group N.V. (PHAR) reported a loss of $0.02 per diluted ordinary share in fiscal year 2024 and $0.00 per diluted ordinary share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) diluted earnings per share went from $0.06 in fiscal year 2019 to $0.00 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.

Earnings and dividends per share are per ordinary share, and share counts are in ordinary shares. PHAR trades in the US as American depositary shares (ADSs), and one ADS represents 10 ordinary shares. The $0.00 of fiscal year 2025 comes to about $0.04 per ADS.